Quanterix Total Liabilities 2016-2025 | QTRX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Quanterix total liabilities from 2016 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Quanterix total liabilities from 2016 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$218.6B
Boston Scientific (BSX)	$157.1B
Stryker (SYK)	$151.4B
EssilorLuxottica (ESLOY)	$135B
Medtronic (MDT)	$118.4B
Lonza Group Ag (LZAGY)	$50B
Haleon (HLN)	$44.2B
ResMed (RMD)	$40.1B
GE HealthCare Technologies (GEHC)	$35.2B
Agilent Technologies (A)	$34.2B
Terumo (TRUMY)	$26B
Koninklijke Philips (PHG)	$24.9B
Insulet (PODD)	$20.2B
Zimmer Biomet Holdings (ZBH)	$19.2B
Baxter (BAX)	$14.8B
Smith & Nephew SNATS (SNN)	$13.8B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$7.1B
Lantheus Holdings (LNTH)	$4.9B
Perrigo (PRGO)	$3.9B
Prestige Consumer Healthcare (PBH)	$3.8B
Haemonetics (HAE)	$3.6B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
ICU Medical (ICUI)	$3.2B
LeMaitre Vascular (LMAT)	$1.8B
QuidelOrtho (QDEL)	$1.8B
AtriCure (ATRC)	$1.5B
Acuren (TIC)	$1.5B